JJ PHARMA CONSULT ApS: Financial statements 2017
CVR: 33257635
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -18,228 and a net result of DKK 585,060 compared with DKK 315,296 the year before. Equity amounted to DKK 2,112,009. The solvency ratio was 99.2%.
- Gross Profit
- -18,228 kr.
- Profit/Loss
- 585,060 kr.
- Equity
- 2,112,009 kr.
- Total Assets
- 2,128,316 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -18 t. | 585 t. | 2.1 mio. | - |
| 2016 | - | -45 t. | 315 t. | 1.6 mio. | - |
| 2015 | - | -17 t. | 582 t. | 1.4 mio. | - |
| 2014 | - | -23 t. | 920 t. | 934 t. | - |
| 2013 | - | -9 t. | 95 t. | 183 t. | - |
Find more companies like JJ PHARMA CONSULT ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
JJ PHARMA CONSULT ApS has published its annual report for 2016. Gross profit came to DKK -44,704, and the net result was DKK 315,296.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity amounted to DKK 16,917,153.
